Supplementary_Table_1 - FDA Reported Use of Patient Experience Data in 2018 Drug Approvals Cameron M. Kieffer Alexis Reisin Miller Benjamin Chacko Andrew S. Robertson 10.25384/SAGE.9970790.v1 https://sage.figshare.com/articles/journal_contribution/Supplementary_Table_1_-_FDA_Reported_Use_of_Patient_Experience_Data_in_2018_Drug_Approvals/9970790 <p>Supplemental Material, Supplementary_Table_1 for FDA Reported Use of Patient Experience Data in 2018 Drug Approvals by Cameron M. Kieffer, Alexis Reisin Miller, Benjamin Chacko and Andrew S. Robertson in Therapeutic Innovation & Regulatory Science</p> 2019-10-11 12:11:13 Patient Focused Drug Development Regulatory Science 21st Century Cures Act Drug Applications Patient Reported Outcomes